Ameriprise Financial Inc Johnson & Johnson Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Ameriprise Financial Inc holds 13,620,197 shares of JNJ stock, worth $2 Billion. This represents 0.6% of its overall portfolio holdings.

Number of Shares

13,620,197

Previous 12,524,843 8.75%

Holding current value

$2 Billion

Previous $1.96 Billion 9.75%

% of portfolio

0.6%

Previous 0.6%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $170 Million - $178 Million	1,095,354 Added 8.75%	13,620,197 $2.15 Billion
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $138 Million - $151 Million	950,458 Added 8.21%	12,524,843 $1.96 Billion
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $408 Million - $458 Million	-2,622,669 Reduced 18.47%	11,574,385 $1.8 Billion
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $112 Million - $121 Million	-728,140 Reduced 4.88%	14,197,054 $2.35 Billion
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $384 Million - $459 Million	-2,544,534 Reduced 14.57%	14,925,194 $2.31 Billion

Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $275 Million - $308 Million	-1,714,223 Reduced 8.94%	17,469,728 $3.09 Billion
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $58.7 Million - $65.3 Million	-363,736 Reduced 1.86%	19,183,951 $3.14 Billion
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $245 Million - $270 Million	-1,453,782 Reduced 6.92%	19,547,687 $3.47 Billion
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $20.1 Million - $22.8 Million	-126,960 Reduced 0.6%	21,001,469 $3.71 Billion
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $191 Million - $211 Million	1,221,877 Added 6.14%	21,128,429 $3.6 Billion
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $92.2 Million - $102 Million	570,900 Added 2.95%	19,906,552 $3.21 Billion
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $166 Million - $178 Million	1,040,348 Added 5.69%	19,335,652 $3.19 Billion
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $256 Million - $285 Million	-1,673,694 Reduced 8.38%	18,295,304 $3.01 Billion
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $85.2 Million - $97.8 Million	621,147 Added 3.21%	19,968,998 $3.14 Billion
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $32.3 Million - $35.3 Million	229,773 Added 1.2%	19,347,851 $2.88 Billion
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $221 Million - $266 Million	1,712,137 Added 9.84%	19,118,078 $2.69 Billion
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $316 Million - $438 Million	2,841,388 Added 19.51%	17,405,941 $2.28 Billion
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $109 Million - $125 Million	-853,024 Reduced 5.53%	14,564,553 $2.12 Billion
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $596,665 - $668,057	-4,700 Reduced 0.03%	15,417,577 $1.99 Billion
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $225 Million - $247 Million	-1,713,068 Reduced 10.0%	15,422,277 $2.15 Billion
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $164 Million - $182 Million	-1,303,384 Reduced 7.07%	17,135,345 $2.4 Billion
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $37.5 Million - $45.1 Million	304,939 Added 1.68%	18,438,729 $2.38 Billion
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $176 Million - $207 Million	1,445,417 Added 8.66%	18,133,790 $3.25 Billion
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $150 Million - $166 Million	-1,258,871 Reduced 7.01%	16,688,373 $2.02 Billion
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $173 Million - $205 Million	1,382,004 Added 8.34%	17,947,244 $2.3 Billion
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $123 Million - $134 Million	-935,041 Reduced 5.34%	16,565,240 $2.31 Billion
Q3 2017 Nov 07, 2017	BUY	$129.47 - $135.38 $2.27 Billion - $2.37 Billion	17,500,281	17,500,281 $2.27 Billion

Others Institutions Holding JNJ

# of Institutions

4,139

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Johnson & Johnson Transaction History